Amgen raised full-year revenue guidance to $38.2–$39.4 billion from $37.1–$38.5 billion following stronger-than-expected sales.
FirstSquawk08/05, 03:07 AM
- $38.2 BLN-$39.4 BLN
- $37.1 BLN-$38.5 BLN
Figures as quoted by FirstSquawk
Related assets
Coming up for AMGN
Explore next
Latest AMGN news
Finnhub09/08, 09:50 PM
Jin1008/21, 10:49 PM
FirstSquawk08/05, 03:07 AM
Amgen raised its full-year adjusted EPS guidance to $22.30-$23.50 from the prior $21.70-$23.10.